Combined effect of the essential oil from Chenopodium ambrosioides and antileishmanial drugs on promastigotes of Leishmania amazonensis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 49, Issue 4, 2007, Pages 257-260

  Monzote, Lianet ^a   Montalvo, Ana Margarita ^a   Scull, Ramón ^b   Miranda, Migdalia ^b   Abreu, Juan ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

Author keywords

Chenopodium ambrosioides; Combination therapy; Leishmania amazonensis

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ESSENTIAL OIL; MEGLUMINE; MEGLUMINE ANTIMONIATE; PENTAMIDINE; UNCLASSIFIED DRUG;

ARTICLE; CHENOPODIUM AMBROSIOIDES; DRUG EFFECT; DRUG POTENTIATION; LEISHMANIA; LEISHMANIASIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROMASTIGOTE;

EID: 34548655035     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652007000400012     Document Type: Article

References (26)

1. ACESTOR, N.; MASINA, S.; WALKER, J. et al. - Establishing two-dimensional gels for the analysis of Leishmania proteomes. Proteomics, 2: 877-879, 2002.
2. ANDERSEN, E.M.; CRUZ-SALDARRIAGA, M.; LLANOS-CUENTAS, A. et al. - Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis Amer. J. trop. Med. Hyg., 72: 133-137, 2005.
3. AREVALO, I.; WARD, B.; MILLER, R. et al. - Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin. infect. Dis., 33: 1847-1851, 2001.
4. BASSELIN, M.; LAWRENCE, F. & ROBERT-GERO, M. - Pentamidine uptake in Leishmania donovani and L. amazonensis promastigotes and axenic amastigotes. Biochem. J., 315: 631-634, 1996.
5. BODLEY, A.L.; McGARRY, M.W. & SHAPIRO, T.A. - Drug cytotoxicity assay for African trypanosomes and Leishmania species. J. infect. Dis., 172: 1157-1159, 1995.
6. BRENDLE, J.J.; OUTLAW, A.; KUMAR, A. et al. - Antileishmanial activities of several classes of aromatic dications. Antimicrob. Agents Chemother., 46: 797-807, 2002.
7. BRYCESON, A. - Current issues in the treatment of visceral leishmaniasis. Med. Microbiol. Immunol., 190: 81-84, 2001.
8. CROFT, S.L. & YARDLEY, Y. - Chemotherapy of leishmaniasis. Curr. Pharmaceut. Des., 8: 319-342, 2002.
9. DAS, V.N.; RANJAN, A.; SINHA, A.N. et al. - A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. J. Ass. Phycns India, 49: 609-613, 2001.
10. GADANO, A.; GURNI, A.; LOPEZ, P.; FERRARO, G. & CARBALLO, M. - In vitro genotoxic evaluation of medicinal plant Chenopodium ambrosioides L. J. Ethnopharm., 81: 11-16, 2002.
11. GUERIN, P.J.; OLLIARO, P.; SUNDAR, S. et al. - Visceral leishmaniasis: current status of control, diagnosis, and treatment, and proposed research and development agenda. Lancet infect. Dis., 2: 494-501, 2002.
12. HERWALDT, B.L. - Leishmaniasis. Lancet, 354: 1191-1199, 1999.
13. IVENS, A.C.; LEWIS, S.M.; BAGHERZADEH, A. et al. - A physical map of the Leishmania major Friedlin genome. Genome Res., 8: 135-145, 1998.
14. JOHNSON, M.D.; MACDOUGALL, C.; OSTROSKY-ZEICHNER, L.; PERFECT, J.R. & REX, J.H. - Combination antifungal therapy. Antimicrob. Agents Chemother., 48: 693-715, 2004.
15. MELBY, P.C. - Recent developments in leishmaniasis. Curr. Opin. infect. Dis., 15: 485-490, 2002.
16. MONZOTE, L.; MONTALVO, A.M.; ALMANONNI, A.S. et al. - Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotherapy, 52: 130-136, 2006.
17. MONZOTE, L.; MONTALVO, A.M.; FONSECA, G.L. et al. - In vitro activities of thiadiazine derivatives against Leishmania amazonensis. Arzneimittel-Forschung., 55: 232-238, 2005.
18. MYLER, P.J.; AUDLEMAN, L.; deVOS, T. et al. - Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genes. Proc. nat. Acad. Sci. (Wash.), 96: 2902-2906, 1999.
19. SEIFERT, K. & CROFT, S.L. - In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob. Agents Chemother., 50: 73-79, 2006.
20. SINGH, S. & SIVAKUMAR, R. - Challenges and new discoveries in the treatment of leishmaniasis. J. infect. Chemother., 10: 307-315, 2004.
21. SOTO-MANCIPE, J.; GROGL, M. & BERMAN, J.D. - Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin. infect. Dis., 16: 417-425, 1993.
22. TEKLEMARIAM, S.; HIWOT, A.G.; FROMMEL, D. et al. - Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Trans. roy. Soc. trop. Med. Hyg., 88: 334-339, 1994.
23. VANNIER-SANTOS, M.A.; MARTINY, A. & DE SOUZA, W. - Cell Biology of Leishmania spp.: invading and evading. Curr. pharmaceut. Des., 8: 297-318, 2002.
24. VANNIER-SANTOS, M.A.; MARTINY, A.; MEYER-FERNANDES, J.R. & DE SOUZA, W. - Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Europ. J. Cell. Biol., 67: 112-119, 1995.
25. VIZOSO PARRA, A.; GARCÍA LÓPEZ, A.; RAMOS RUIZ, A. et al. - Evaluación mutagénica de un extracto fluído con un menstruo etanólico al 70% de Teloxis ambrosioides L. weber (Apasote). Rev. cuba. Plant. med., 5: 102-105, 2002.
26. ZHAO, L.; WIENTJES, M.J. & AU, J.L. - Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin. Cancer Res., 10: 7994-8004, 2004.